We and others earlier reported that the EphA2 expression is linked to poor outcome in NSCLC and more recently both EGFR as well as VEGFR2 signaling has been associated with EphA2 [29, 30, 31, 32, 33, 34]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.